Skip to content

Abiojoint EVO

by Abiogen Pharma S.p.A.

Ref 11021

Active European Union

CE MDR

Valid until

19 Mar 2031

CE MDR certificate

FDA recalls

Not applicable

No FDA record for this device

Documents

2 certificates

Certifier ISTITUTO SUPERIORE DI SANITA'

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 24 Oct 2026. What this means

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number805651586P90040211001ZL Basic UDI-DI 08056515860747UDI-DIDate29 May 2026RegisteredStatusActive

Certificates

2 certificates · EUDAMED

EUDAMED certificates (2)

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device Name
ABIO32/18
Model / Reference
11021
Primary DI / UDI-DI
08056515860747
Basic UDI-DI
805651586P90040211001ZL
EMDN Code
P900402 Resorbable filling and reconstruction devices
Device Class
Class III
EU market of registration
France

Manufacturer details

EUDAMED SRN
IT-MF-000029973

Other devices from Abiogen Pharma S.p.A.

Properties

  • Sterile
  • Implantable

Other properties (11)

  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No